Vandetanib (ZD6474) in the Treatment of Medullary Thyroid Cancer
{{output}}
Vandetanib (ZD6474) is an orally bioavailable small molecule tyrosine kinase inhibitor of multiple growth factor receptors, including RET (Rearrange during transfection), vascular endothelial growth factor receptor-2 (VEGFR-2) and epidermal growth factor recep... ...